Jul 26, 2021 09:00AM
Jun 22, 2021 10:17AM
May 5, 2021 12:20PM
May 3, 2021 09:00AM
Apr 27, 2021 08:30AM
Apr 12, 2021 08:00AM
Apr 8, 2021 09:00AM Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women
Mar 31, 2021 11:03AM
Feb 24, 2021 09:15AM
Feb 3, 2021 09:00AM
Dec 31, 2020 09:00AM
Nov 23, 2020 08:30AM
Oct 7, 2020 08:53AM
Oct 6, 2020 08:30AM Generex Subsidiary NuGenerex Immuno-Oncology Announces World Class Scientific Advisory Board Appointments for its COVID-19 Vaccine Development Program
Aug 25, 2020 03:10PM
Aug 25, 2020 12:19PM
Aug 19, 2020 09:00AM
Aug 17, 2020 09:00AM
Aug 13, 2020 09:30AM
Aug 4, 2020 09:00AM
Jul 27, 2020 09:15AM Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020
Jul 20, 2020 09:00AM
Jul 1, 2020 09:00AM
Apr 27, 2020 08:30AM
Apr 14, 2020 09:00AM
Apr 6, 2020 09:09AM
Mar 2, 2020 12:50PM
Mar 2, 2020 09:30AM Generex Biotechnology Appoints Independent Director S. Gail Eckhardt, MD to the NuGenerex Immuno-Oncology Board of Directors
Feb 10, 2020 09:00AM
Feb 4, 2020 09:56AM
Feb 4, 2020 09:56AM
Jan 17, 2020 09:00AM
Jan 16, 2020 12:28PM
Nov 5, 2019 09:15AM
Oct 15, 2019 09:00AM Generex Biotechnology Announces Merger with Public Vehicle for Public Trading of NuGenerex Immuno-Oncology
Oct 10, 2019 09:15AM
Oct 1, 2019 09:15AM
Sep 30, 2019 09:49AM
Sep 27, 2019 09:00AM
Sep 20, 2019 11:03AM
Sep 17, 2019 09:00AM
Sep 16, 2019 02:51PM Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
Sep 12, 2019 12:20PM
Sep 10, 2019 08:30AM
Sep 9, 2019 09:00AM
Sep 6, 2019 12:19PM
Sep 3, 2019 01:50PM
Aug 26, 2019 11:09AM
Aug 23, 2019 03:05PM Generex Biotechnology Reiterates 1:1 Stock Dividend for Clarity in the Market and Provides Details on Capital Structure
Aug 19, 2019 09:00AM

322,870 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All